Biomedicines (Jul 2022)

Interaction Interface of Aβ<sub>42</sub> with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD

  • Alexei A. Adzhubei,
  • Anna P. Tolstova,
  • Maria A. Strelkova,
  • Vladimir A. Mitkevich,
  • Irina Yu. Petrushanko,
  • Alexander A. Makarov

DOI
https://doi.org/10.3390/biomedicines10071663
Journal volume & issue
Vol. 10, no. 7
p. 1663

Abstract

Read online

Alzheimer’s disease (AD) is a neurodegenerative disease accompanied by progressive cognitive and memory dysfunction due to disruption of normal electrotonic properties of neurons and neuronal loss. The Na,K-ATPase interaction with beta amyloid (Aβ) plays an important role in AD pathogenesis. It has been shown that Na,K-ATPase activity in the AD brain was significantly lower than those in age-matched control brain. The interaction of Aβ42 with Na,K-ATPase and subsequent oligomerization leads to inhibition of the enzyme activity. In this study interaction interfaces between three common Aβ42 isoforms, and different conformations of human Na,K-ATPase (α1β1) have been obtained using molecular modeling, including docking and molecular dynamics (MD). Interaction sites of Na,K-ATPase with Aβ42 are localized between extracellular parts of α- and β- subunits and are practically identical for Na,K-ATPase at different conformations. Thermodynamic parameters for the formation of Na,K-ATPase:Aβ42 complex at different conformations acquired by isothermal titration calorimetry (ITC) are similar, which is in line with the data of molecular modeling. Similarity of Na,K-ATPase interaction interfaces with Aβ in all conformations allowed us to cross-screen potential inhibitors for this interaction and find pharmaceutical compounds that could block it.

Keywords